Print Page   |   Contact Us   |   Sign In   |   Join
News and Press: Member Organization News

Stryker to Acquire Entellus Medical for $662 Million

Thursday, December 7, 2017   (0 Comments)
Share |

SOURCE via MiBiz


KALAMAZOO — Stryker Corp.said it has a deal to buyEntellus Medical Inc.of Plymouth, Minn. in a transaction valued at $662 million.

The Kalamazoo-based Stryker (NYSE: SYK) will pay $24 per share for Entellus Medical (Nasdaq: ENTL), an 11-year-old medical technology company producing products for minimally invasive treatments for ear, nose and throat (ENT) diseases. The deal is subject to approval by Entellus shareholders and federal antitrust review.

“Entellus is a leader in the ENT segment and offers a comprehensive portfolio of products that enable physicians to conveniently and comfortably perform a broad range of ENT procedures,” Timothy Scannell, group president for the MedSurg and Neurotechnology division at Stryker, said in a statement.

Entellus in 2016 had revenue of $75.2 million, up 22 percent from the $61.6 million in 2016, with a net loss of $28.7 million.

The company had sales of $23.3 million in the third quarter of 2017 with a net loss of $3.2 million. Through nine months of 2017, Entellus generated sales of $64.5 million and reported a net loss of $19.6 million.

Guggenheim Securitiesserved as financial adviser, andSkadden, Arps, Slate, Meagher & Flom LLPserved as outside legal counsel for Stryker.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal